These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33734579)

  • 1. MX2 mediates establishment of interferon response profile, regulates XAF1, and can sensitize melanoma cells to targeted therapy.
    Juraleviciute M; Nsengimana J; Newton-Bishop J; Hendriks GJ; Slipicevic A
    Cancer Med; 2021 Apr; 10(8):2840-2854. PubMed ID: 33734579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MX 2 is a novel regulator of cell cycle in melanoma cells.
    Juraleviciute M; Pozniak J; Nsengimana J; Harland M; Randerson-Moor J; Wernhoff P; Bassarova A; Øy GF; Trøen G; Flørenes VA; Bishop DT; Herlyn M; Newton-Bishop J; Slipicevic A
    Pigment Cell Melanoma Res; 2020 May; 33(3):446-457. PubMed ID: 31660681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis.
    Leaman DW; Chawla-Sarkar M; Vyas K; Reheman M; Tamai K; Toji S; Borden EC
    J Biol Chem; 2002 Aug; 277(32):28504-11. PubMed ID: 12029096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-γ Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4.
    Mo X; Zhang H; Preston S; Martin K; Zhou B; Vadalia N; Gamero AM; Soboloff J; Tempera I; Zaidi MR
    Cancer Res; 2018 Jan; 78(2):436-450. PubMed ID: 29150430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of XAF1 expression in human colon cancer cell by interferon beta: activation by the transcription regulator STAT1.
    Sun Y; Qiao L; Xia HH; Lin MC; Zou B; Yuan Y; Zhu S; Gu Q; Cheung TK; Kung HF; Yuen MF; Chan AO; Wong BC
    Cancer Lett; 2008 Feb; 260(1-2):62-71. PubMed ID: 18035482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity.
    Hartman ML; Sztiller-Sikorska M; Gajos-Michniewicz A; Czyz M
    Cells; 2020 Jan; 9(1):. PubMed ID: 31936151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvastatin exerts an antitumor effect in vemurafenib-resistant melanoma cells.
    Nishiya M; Yasuhira S; Shibazaki M; Oikawa H; Masuda T; Maesawa C
    Anticancer Drugs; 2019 Jun; 30(5):451-457. PubMed ID: 30920401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BIK is involved in BRAF/MEK inhibitor induced apoptosis in melanoma cell lines.
    Borst A; Haferkamp S; Grimm J; Rösch M; Zhu G; Guo S; Li C; Gao T; Meierjohann S; Schrama D; Houben R
    Cancer Lett; 2017 Sep; 404():70-78. PubMed ID: 28720543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
    Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC
    J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.
    Arora V; Cheung HH; Plenchette S; Micali OC; Liston P; Korneluk RG
    J Biol Chem; 2007 Sep; 282(36):26202-9. PubMed ID: 17613533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1).
    Chawla-Sarkar M; Leaman DW; Jacobs BS; Tuthill RJ; Chatterjee-Kishore M; Stark GR; Borden EC
    J Interferon Cytokine Res; 2002 May; 22(5):603-13. PubMed ID: 12060499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MEK Inhibitors Trametinib and Cobimetinib Induce a Type I Interferon Response in Human Keratinocytes.
    Lulli D; Carbone ML; Pastore S
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of human MX2 gene suppresses cell proliferation, migration, and invasion via ERK/P38/NF-κB pathway in glioblastoma cells.
    Wang H; Guan Q; Nan Y; Ma Q; Zhong Y
    J Cell Biochem; 2019 Nov; 120(11):18762-18770. PubMed ID: 31265172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The JAK/STAT pathway is not sufficient to sustain the antiproliferative response in an interferon-resistant human melanoma cell line.
    Jackson DP; Watling D; Rogers NC; Banks RE; Kerr IM; Selby PJ; Patel PM
    Melanoma Res; 2003 Jun; 13(3):219-29. PubMed ID: 12777975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentivirus-mediated downregulation of MAT2B inhibits cell proliferation and induces apoptosis in melanoma.
    Lei Y; Zhang B; Zhang Y; Zhao Y; Sun J; Zhang X; Yang S
    Int J Oncol; 2016 Sep; 49(3):981-90. PubMed ID: 27573889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic melanoma cells evade immune detection by silencing STAT1.
    Osborn JL; Greer SF
    Int J Mol Sci; 2015 Feb; 16(2):4343-61. PubMed ID: 25690042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma.
    Wong LH; Krauer KG; Hatzinisiriou I; Estcourt MJ; Hersey P; Tam ND; Edmondson S; Devenish RJ; Ralph SJ
    J Biol Chem; 1997 Nov; 272(45):28779-85. PubMed ID: 9353349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MX2 is an interferon-induced inhibitor of HIV-1 infection.
    Kane M; Yadav SS; Bitzegeio J; Kutluay SB; Zang T; Wilson SJ; Schoggins JW; Rice CM; Yamashita M; Hatziioannou T; Bieniasz PD
    Nature; 2013 Oct; 502(7472):563-6. PubMed ID: 24121441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse Mx2 gene: organization, mRNA expression and the role of the interferon-response promoter in its regulation.
    Asano A; Jin HK; Watanabe T
    Gene; 2003 Mar; 306():105-13. PubMed ID: 12657472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous growth factors bFGF, EGF and HGF do not influence viability and phenotype of V600EBRAF melanoma cells and their response to vemurafenib and trametinib in vitro.
    Zalesna I; Osrodek M; Hartman ML; Rozanski M; Sztiller-Sikorska M; Niewinna K; Nejc D; Czyz M
    PLoS One; 2017; 12(8):e0183498. PubMed ID: 28829835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.